SCM
RETA

Suvretta Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Suvretta Capital Management’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-108,832
Closed -$11.1M – 106
2023
Q2 		$11.1M Buy
108,832
+93,732
+621% +$9.56M 0.59% 50
2023
Q1 		$1.37M Buy
+15,100
New +$1.37M 0.06% 71